Antibodies
Login
Search   
APC/Cy7 anti-human CD13 Antibody
APC/Cy7 anti-human CD13 Antibody
301709 25 tests $130.00     
301710 100 tests $265.00     

Product Details

Clone: WM15
Isotype: Mouse IgG1, κ
Isotype Control:APC/Cy7 Mouse IgG1, κ Isotype Ctrl
Workshop
Number:
IV M44
Reactivity: Human, Cross-Reactivity: Chimpanzee, Baboon, Cotton-topped Tamarin
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA (origin USA).
Preparation: The antibody was purified by affinity chromatography, and conjugated with APC/Cy7 under optimal conditions. The solution is free of unconjugated APC/Cy7 and unconjugated antibody.
Storage & Handling: The antibody solution should be stored undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Application:

FC - Quality tested

Recommended Usage:

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. Test size products are transitioning from 20 µl to 5 µl per test. Please check your vial or your CoA to find the suggested use of this reagent per million cells in 100 µl staining volume or per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application. Read more at www.biolegend.com/testsize regarding the test size change.

COA:
Enter Lot#:   
Application
Notes:

Additional reported applications (for the relevant formats) include: inhibition of tumor-cell invasion and blocking of aminopeptidase activities2,3, and immunohistochemical staining of acetone-fixed frozen tissue sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/μg, Azide-Free, 0.2 μm sterile-filtered) is recommended for functional assays (Cat. No. 301708).

  Cy3, Cy5, Cy5.5 and Cy7 are subject to proprietary rights of GE Healthcare Bio-Sciences Corp. and Carnegie Mellon University and made and sold under license from GE Healthcare Bio-Sciences Corp. Sale of this product is licensed for research use only.
Application
References:

1. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York.
2. Saiki I, et al. 1993. Int J Cancer. 54:137. (Block)
3. Rosenzwajg M, et al. 2000. Blood 95:453. (Block)
4. Kawase M, et al. 2008. J Virol. 83:712. (Block) PubMed

Human peripheral blood granulocytes stained
Human peripheral blood granulocytes stained with WM15 APC/Cy7 and overlayed with isotype control


Compare all formats



Description:

CD13 is a 150-170 kD type II transmembrane glycoprotein also known as aminopeptidase N, APN, and gp150. This zinc metallopeptidase as a homodimer is expressed on granulocytes, myeloid progenitors, endothelial cells, epithelial cells and subset of granular lymphoid cells. It is not expressed on platelets or erythrocytes. CD13 is thought to be involved in the metabolism of many regulatory peptides and functions in antigen processing and the cleavage of chemokines such as MIP-1. CD13 serves as the cellular receptor for Coronavirus.

Other Names: Aminopeptidase N, APN, gp150
Structure: Zinc metallopeptidase, type II integral membrane glycoprotein, 150-170 kD
Distribution: Granulocytes, monocytes, myeloid progenitors, endothelial and epithelial cells, granular lymphocyte subset
Function: Zinc-binding metalloproteinase, antigen processing, cleaves MIP-1 chemokine
Ligand Receptor: Coronavirus receptor
Antigen
References:

1. Shipp M, et al. 1993. Blood 82:1052.
2. Larsen S, et al. 1996. J. Exp. Med. 184:183.

GeneID: 290
Latest Publications: View the latest CD13 articles on HighwirePress.com
UniProt: View information about CD13 on UniProt.org
Keywords: APC/Cy7 anti-human CD13, WM15, APC/Cy7, Aminopeptidase N, APN, gp150, Human, Cross-Reactivity: Chimpanzee, Baboon, Cotton-topped Tamarin, Immunology, Antibodies
Related Products

DescriptionCloneApplications
Cell Staining BufferFC, ICC, ICFC
RBC Lysis Buffer (10X)FC, ICFC
APC/Cy7 Mouse IgG1, κ Isotype CtrlMOPC-21FC, ICFC
Human TruStain FcX™ (Fc Receptor Blocking Solution)FC, ICC, ICFC

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
x
Compare Data Across All Formats
This data display is provided for general comparisons between formats. Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors. If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-human CD13
    Human peripheral blood lymphocytes, monocytes

    Human peripheral blood lymphocytes, monocytes and granulocytes stained with WM15 APC

  • PE anti-human CD13
    Human peripheral blood granulocytes stained

    Human peripheral blood granulocytes stained with WM15 PE

  • Purified anti-human CD13
    Human peripheral blood granulocytes stained

    Human peripheral blood granulocytes stained with purified WM15, followed by anti-mouse IgGs FITC

  • LEAF™ Purified anti-human CD13
    Human peripheral blood granulocytes stained

    Human peripheral blood granulocytes stained with LEAF™ purified WM15, followed by anti-mouse IgGs FITC

  • APC/Cy7 anti-human CD13
    Human peripheral blood granulocytes stained

    Human peripheral blood granulocytes stained with WM15 APC/Cy7 and overlayed with isotype control

  • PE/Cy7 anti-human CD13
    Human peripheral blood granulocytes were

    Human peripheral blood granulocytes were stained with CD13 (clone WM15) PE/Cy7 (filled histogram) or mouse IgG1, κ PE/Cy7 isotype control (open histogram).

x
Copyright © 2011 BioLegend, Inc. All rights reserved.